Navigation Links
Doyle praises Frist's new stem cell research position

Madison, Wis. - Gov. Jim Doyle on Monday expressed hope for the future of stem cell research, lauding Senate Majority Leader Bill Frist's recent decision to support removal of some of the current limitations on such research.

Doyle made his comments at the groundbreaking of the University of Wisconsin-Madison's Interdisciplinary Research Complex, where he also praised Wisconsin's m......

Full article >>> Complex, the latest building constructed under the HealthStar initiative. The IRC will be dedicated to building connections with researchers and bring their research into direct clinical care.

"We're creating a new taxonomy of science, a new way of collaborating that will change the tone of science in the next five years," said Paul DeLuca, vice dean of the UW Medical School.


Full article >>> is a step to ensure Wisconsin remains a leader in the forefront of medical research."

Les Chappell is a writer for WTN based in Madison. He can be reached at


Full article >>>
'"/> By Les Chappell 08/01/05

Related biology technology :

1. Doyle urges Legislature to support biofuels program
2. Doyle urges support of higher education spending
3. Doyle announces technology tax credits for Berbee
4. Doyle joins governors in support of stem cell bill
5. Doyle announces new energy, global warming policies
6. Doyle outlines spending for Medical College, UWM
7. Doyle wants sales tax applied to digital downloads
8. Doyle proposes $2M for venture capital center
9. Doyle seeks $30M for e-medical record adoption
10. Doyle says Congress should lift stem cell restrictions
11. Kanavas rips Doyle for taxing Internet
Post Your Comments:

(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE ... has adopted a stockholder rights plan (Rights Plan) in ... operating loss carryforwards (NOLs) under Section 382 of the ... --> PharmAthene,s use of its NOLs could ... change" as defined in Section 382 of the Code. ...
(Date:11/25/2015)... CITY , Nov. 25, 2015 /PRNewswire/ - Aeterna ... affirms that its business and prospects remain fundamentally ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation ... to completion following review of the final interim ... Phase 2 Primary Endpoint in men with heavily ...
(Date:11/24/2015)... Malaysia , Nov. 24, 2015  Asia-Pacific ... contract research organisation (CRO) market. The trend of ... in lower margins but higher volume share for ... capacity and scale, however, margins in the CRO ... Organisation (CRO) Market ( ), finds ...
(Date:11/24/2015)... Mass. (PRWEB) , ... November 24, 2015 , ... ... to maintain healthy metabolism. But unless it is bound to proteins, copper is ... of Health (NIH), researchers at Worcester Polytechnic Institute (WPI) will conduct a systematic ...
Breaking Biology Technology:
(Date:11/17/2015)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... of broadly enabling, pressure cycling technology ("PCT")-based sample preparation ... it has received gross proceeds of $745,000 from an ... "Offering"), increasing the total amount raised to date in ... are expected in the near future. ...
(Date:11/12/2015)... , Nov. 12, 2015  Arxspan has entered ... MIT and Harvard for use of its ArxLab ... management tools. The partnership will support the institute,s ... and chemical research information internally and with external ... used for managing the Institute,s electronic laboratory notebook, ...
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
Breaking Biology News(10 mins):